Literature DB >> 11588839

Natural history of prostate cancer--epidemiologic considerations.

G J Miller1, K C Torkko.   

Abstract

Multicentricity, heterogeneity, and sampling error complicate the study of the natural history of prostate cancer. Carcinomas previously termed "latent" are probably similar to those detected clinically. The diagnosis of carcinoma is only made following biopsy and histologic confirmation. Estimates of grade and stage made at the time of detection are prone to sampling error and are likely to change following examination of radical prostatectomy specimens. In regions with lower life expectancies, the problem of prostate cancer becomes a lower priority due to its association with aging. Access to care, numbers of medical facilities, and differing public health priorities make international rates difficult to compare. However, in view of the high worldwide prevalence of the disease, further epidemiologic studies of prostate cancer are warranted.

Entities:  

Mesh:

Year:  2001        PMID: 11588839     DOI: 10.1093/oxfordjournals.epirev.a000780

Source DB:  PubMed          Journal:  Epidemiol Rev        ISSN: 0193-936X            Impact factor:   6.222


  9 in total

1.  Differential expression of E-cadherin and P-cadherin in pT3 prostate cancer: correlation with clinical and pathological features.

Authors:  Catarina Ferreira; João Lobo; Luís Antunes; Paula Lopes; Carmen Jerónimo; Rui Henrique
Journal:  Virchows Arch       Date:  2018-07-13       Impact factor: 4.064

2.  [Survival of patients diagnosed with prostate cancer and monitored in primary care].

Authors:  Gabriel J Díaz Grávalos; Gerardo Palmeiro Fernández; Inmaculada Casado Górriz; Margarita Arandia García; Susana Alvarez Araújo; Mónica González Dacosta
Journal:  Aten Primaria       Date:  2007-11       Impact factor: 1.137

3.  Inhibition of stathmin1 accelerates the metastatic process.

Authors:  Karin Williams; Ritwik Ghosh; Premkumar Vummidi Giridhar; Guangyu Gu; Thomas Case; Scott M Belcher; Susan Kasper
Journal:  Cancer Res       Date:  2012-08-21       Impact factor: 12.701

Review 4.  The impact of obesity on prostate cancer.

Authors:  Joep G H van Roermund; J Alfred Witjes
Journal:  World J Urol       Date:  2007-05-30       Impact factor: 4.226

5.  A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.

Authors:  Sanmitra Basu; Subhadipa Majumder; Ankur Bhowal; Alip Ghosh; Sukla Naskar; Sumit Nandy; Subhabrata Mukherjee; Rajan Kumar Sinha; Keya Basu; Dilip Karmakar; Soma Banerjee; Sanghamitra Sengupta
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

6.  Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance.

Authors:  Katerina Pestova; Adam J Koch; Charles P Quesenberry; Jun Shan; Ying Zhang; Amethyst D Leimpeter; Beth Blondin; Svetlana Sitailo; Lela Buckingham; Jing Du; Huixin Fei; Stephen K Van Den Eeden
Journal:  BMC Cancer       Date:  2018-01-02       Impact factor: 4.430

7.  Disadvantageous Socioeconomic Position at Specific Life Periods May Contribute to Prostate Cancer Risk and Aggressiveness.

Authors:  Sreenath Madathil; Christine Blaser; Belinda Nicolau; Hugues Richard; Marie-Élise Parent
Journal:  Front Oncol       Date:  2018-11-15       Impact factor: 6.244

8.  Prostate resected weight and postoperative prostate cancer incidence after transurethral resection of the prostate: A population-based study.

Authors:  Fu-Chao Liu; Kuo-Chun Hua; Jr-Rung Lin; See-Tong Pang; Huang-Ping Yu
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

9.  Should active surveillance in prostate cancer patients be based on a single histological assessment?

Authors:  Lukasz Nyk; Tomasz Golabek; Jakub Dobruch; Michał Andrzej Skrzypczyk; Tomasz Dzik; Maciej Wysocki; Piotr L Chłosta; Andrzej Borówka
Journal:  Cent European J Urol       Date:  2014-08-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.